TCL Archive Abraxane-Gemcitabine Combination Extends Overall Survival in Phase III Trial January 31, 2014
TCL Archive In Brief: Hammer Reappointed chairman; Wyngaarden Names Ferguson of Baylor As OMAR Director July 29, 1988